Condition: Stage I Testicular Seminoma · Stage I Testicular Nonseminomatous Germ Cell Tumor · Gastrointestinal Stromal Tumors · Sponsor: Centre Oscar Lambret
This is a multicenter, interventional, randomized study among adult patients recently diagnosed with a rare tumor (\<12 months). The study will aim to compare compliance with the personalized post-treatment surveillance plan, established for each patient according to national guidelines, when the surveillance is conducted in person by a hospital-based physician (control arm) or remotely by a trained nurse (experimental arm).
This description comes directly from the study's public registry record.
Laurence ROTSAERT · 0320295860 / 0320295918 · l-rotsaert@o-lambret.fr
Fanny BEN OUNE · 0320295918 · f-benoune@o-lambret.fr
Always discuss trial participation with your own doctor first.
| CHU Amiens | Amiens, France | Not Yet Recruiting |
| Centre François Baclesse | Caen, France | Not Yet Recruiting |
| Centre Oscar Lambret | Lille, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05500391